Pasar al contenido principal

User account menu

  • Abrir sesión

Idiomas

  • English
  • Français
  • Português
  • Español
  • العربية
  • Pусский

Navegación principal

  • Acerca de ISSUP

    • 10 Years of ISSUP
    • Fundamentos de ISSUP
    • Membresía
      • Criterios de membresía
      • Código Ético
      • Who is ISSUP for?
    • Noticias
      • Newsletters
    • Eventos del ISSUP
    • Socios internacionales
    • Gobernanza
    • ISSUP Scientific Council
    • Friends of ISSUP (USA)
    • Premio ISSUP
      • Premio basado en la evidencia
      • Premio a la iniciativa local
      • Premio a los Servicios
      • Excellence in Training Provision
      • Outstanding Contribution to ISSUP Award
    • In Memoriam
    • Acknowledgements
    • Guías de orientación relativas al sitio web de ISSUP
    • Contacta a ISSUP
    • FAQs - Frequently Asked Questions
  • Capacitación

    • Centro de Aprendizaje en Línea
      • Cómo registrarse
      • Cursos Autodirigidos UTC
    • Currículos Universales (UPC/UTC/URC)
      • Currículo de Prevención Universal
      • Currículo de Tratamiento Universal
      • Currículo Universal de Recuperación
      • ¿Cómo conseguir acceso a los cursos de UPC y UTC?
      • Proveedores de cursos
      • Cómo hacerse un proveedor de cursos: Proceso de solicitud
    • Resources
      • Glossary
      • The ISSUP Exchange
      • ISSUP Webinars
      • INEP Plus
      • Prevention Insights Video Series
      • Prevention Lists
      • Recovery Support
      • Quality in Treatment
      • Certificación ICAP
      • HealthEKnowledge
      • WiRED International
      • Cuaderno de trabajo de prevención de la SPR-ISSUP
    • Jobs and Opportunities
  • Knowledge Share

    • Search in the Knowledge Share
    • ADDICTOLOGY Journal
      • Latest Issue
  • Capítulos Nacionales

    • Africa
      • ISSUP Botswana
      • ISSUP Côte d’Ivoire
      • ISSUP Egypt
      • ISSUP The Gambia
      • ISSUP Kenya
      • ISSUP Namibia
      • ISSUP Nigeria
      • ISSUP South Africa
      • ISSUP Tanzania
      • ISSUP Togo
      • ISSUP Uganda
      • ISSUP Zambia
    • The Americas
      • ISSUP Argentina
      • ISSUP The Bahamas
      • ISSUP Brazil
      • ISSUP Canada
      • ISSUP Chile
      • ISSUP Colombia
      • ISSUP Ecuador
      • ISSUP El Salvador
      • ISSUP Guatemala
      • ISSUP Mexico
      • ISSUP Panama
      • ISSUP Paraguay
      • ISSUP Peru
      • ISSUP United States
    • Asia
      • ISSUP Afghanistan
      • ISSUP India
      • ISSUP Indonesia
      • ISSUP Kazakhstan
      • ISSUP Lebanon
      • ISSUP Malaysia
      • ISSUP in Pakistan
      • ISSUP Philippines
      • ISSUP Qatar
      • ISSUP Korea
      • ISSUP Sri Lanka
      • ISSUP Thailand
      • ISSUP Türkiye
      • ISSUP United Arab Emirates
      • ISSUP Uzbekistan
      • ISSUP Vietnam
    • Europe
      • ISSUP Czech Republic
      • ISSUP Greece
      • ISSUP Italy
      • ISSUP Spain
      • ISSUP Ukraine
      • ISSUP United Kingdom
    • How to Become a National Chapter
    • ISSUP National Chapters' Advisory Committee
  • Events

    • Search through all events
    • Eventos del ISSUP
      • Indonesia 2025
      • Thessaloniki 2024
      • Buenos Aires 2023
      • Manila 2022
      • Abu Dhabi 2022
      • Virtual 2021
      • Africa 2020 (Virtual)
      • Viena 2019
      • Nairobi 2018
      • México 2017
      • Campinas 2016
      • Bangkok 2015
  • Foro

    • A–Z
  • My ISSUP

    • Member Directory
    • Solicitar la membresía

Adderall: Evidence-Informed Treatment, Safe Use, and Intervention Resources in New York

Guidance on Adderall use, risks, and interventions in New York. Curated by Benjamin Zohar, NCACIP—practical, ethical, and evidence-informed care.

Moderators

Profile picture for user help
Benjamin Zohar, NCACIP
Intervention New York
DiscussionsArchivosImágenesVideosEnlacesEventosKnowledge ShareTodo(s)
Benjamin Zohar, NCACIP

2025 ADHD Stimulant Shortage: Patient & Provider Guidance

Benjamin Zohar, NCACIP - 27 November 2025
Benjamin Zohar, NCACIP is an addiction intervention professional specializing in international systems, crisis navigation, and clinical-policy translation.
Stimulant medications, including Adderall, remain in active shortage across multiple regions in 2025, affecting treatment stability and increasing counterfeit-pill risks. This article explains the latest data behind the shortage and outlines safe, practical steps patients and professionals can take when prescriptions are unavailable.
  • Lee más sobre 2025 ADHD Stimulant Shortage: Patient & Provider Guidance
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals

Benjamin Zohar, NCACIP - 27 November 2025
Benjamin Zohar Adderall interventionist New York

The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals

Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of InterventionNY

This article is intended for education and professional development and does not replace individualized medical, psychiatric, or pharmaceutical consultation.

Summary

The 2025 global shortage of Adderall and related stimulant medications is affecting patient stability, treatment continuity, and public health systems across multiple regions. Driven...

  • Lee más sobre The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

DEA Adjusts Stimulant Production Quotas Amid Ongoing ADHD Medication Shortages in 2025

Benjamin Zohar, NCACIP - 27 November 2025
The DEA’s stimulant quota revisions for 2024–2025 represent a significant regulatory acknowledgment of rising ADHD treatment needs. However, the 2025 ADHD medication shortage persists due to complex supply-chain, manufacturing, and distribution factors. Ongoing monitoring from ASHP, FDA, and the DEA remains essential as providers and patients navigate disrupted access to critical medications.
  • Lee más sobre DEA Adjusts Stimulant Production Quotas Amid Ongoing ADHD Medication Shortages in 2025
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

Best Rehabs in Long Island, NY: A Comprehensive Guide to Recovery Resources

Benjamin Zohar, NCACIP - 22 November 2025

🏥 Best Rehabs in Long Island, NY: Your Complete Guide to Recovery

Author: Benjamin Zohar, NCACIP (Addiction Professional) | Published: November 22, 2025 | Category: Treatment Resources & Recovery Support

🌟 Finding the right addiction treatment center can be a life-changing decision. Long Island, New York, offers a diverse range of rehabilitation facilities that provide evidence-based care for individuals struggling with substance use disorders. This comprehensive guide explores the best rehabs in Long Island, helping you or your loved ones navigate the path to recovery with confidence and...

  • Lee más sobre Best Rehabs in Long Island, NY: A Comprehensive Guide to Recovery Resources
  • ISSUP members can join Networks to comment – Sign in or become a member

Upcoming Events

There aren't any upcoming events
All Events
Contact Us

Stay Connected

Newsletter

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy